| [1] | Sheng C, Zhang W. New Lead Structures in Antifungal Drug Discovery[J]. Curr Med Chem,2011, 18(5): 733. |
| [2] | Borate HB, Maujan SR, Sawargave SP, et al. Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents[J]. Bioorg Med Chem Lett,2010, 20(2):722. |
| [3] | Guillon R, Pagniez F, Rambaud C, et al. Design, synthesis, and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3- (1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships[J]. Chem Med Chem,2011, 6(10):1806. |
| [4] | Guillon R, Pagniez F, Giraud F, et al. Design, synthesis, and in vitro antifungal activity of 1-[(4-substituted-benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols[J].Chem Med Chem,2011, 6(5):816. |
| [5] | Sheng C, Zhang W, Zhang M, et al. Homology Modeling of Lanosterol 14-Demethylase of Candida albicans and Aspergillus fumigatus and Insights into the Enzyme-Substrate Interactions[J]. J Biomol Struct & Dyn, 2004, 22(1):91. |
| [6] | Sheng C, Wang W, Che X, et al. Improved Model of Lanosterol 14alpha-Demethylase by LigandSupported Homology Modeling: Validation by Virtual Screening and Azole Optimization[J]. Chem Med Chem,2010, 5(3): 390. |
| [7] | Sheng C, Miao Z, Ji H, Threedimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: activesite characterization and insights into azole binding. Antimicrob Agents[J].Chemother,2009, 53(8):3487. |
| [8] | Sheng C, Zhang W, Ji H, et al. Structure-based Optimization of Azole Antifungal Agents by CoMFA, CoMSIA and Molecular Docking[J]. J Med Chem, 2006, 49(8):2512. |